Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY)

CUSIP: 45790W108

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
64,967,756
Total 13F shares
48,723,016
Share change
+14,563,860
Total reported value
$204,637,627
Put/Call ratio
45%
Price per share
$4.20
Number of holders
77
Value change
+$58,070,290
Number of buys
44
Number of sells
29

Quarterly Holders Quick Answers

What is CUSIP 45790W108?
CUSIP 45790W108 identifies INZY - Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) as of Q3 2023

As of 30 Sep 2023, Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) was held by 77 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 48,723,016 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., Pivotal bioVenture Partners Investment Advisor LLC, Sofinnova Investments, Inc., Rock Springs Capital Management LP, SAMLYN CAPITAL, LLC, EVENTIDE ASSET MANAGEMENT, LLC, FMR LLC, NEA Management Company, LLC, VANGUARD GROUP INC, and BlackRock Inc.. This page lists 77 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.